Wall Street Journal: Generative AI Makes Headway in Healthcare

Belle Lin of the Wall Street Journal’s latest piece discusses new generative AI technology applications for healthcare. Read the full article here: https://www.wsj.com/articles/generative-ai-makes-headway-in-healthcare-cb5d4ee2

The innovations mentioned span Abridge’s automated clinical notes capture, Syntegra’s synthetic medical data which has been validated at Janssen, and Atropos Platform for evidence-backed clinical Q&A.

Atropos Health aims to deliver personalized evidence for every clinical decision and research inquiry. In most cases, this will entail gleaning new clinical insights for patient cohorts not yet well characterized in the medical literature.

To produce novel retrospective observational research that’s trustworthy: “Atropos pulls from millions of anonymized patient records from sources such as a healthcare provider’s cloud-based patient records to produce observational research, Dr. Brigham Hyde said. Before being shared with doctors, its results are reviewed by the startup’s medical director.”

How does Atropos answer clinical questions with publication-grade, clinician-reviewed real-world evidence in 48 hours?